Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Oxford Cancer Biomarkers Ltd.
DescriptionCompanion diagnostic biomarker test for proteasome inhibitor drugs
Molecular Target Proteasome
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentDiscovery
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify patients that respond to proteasome inhibitors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today